GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 77 filers reported holding GLYCOMIMETICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,278 | -65.0% | 3,395 | -15.9% | 0.00% | – |
| Q4 2022 | $12,235 | +307.8% | 4,038 | -20.2% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 5,063 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -98.8% | 5,063 | -97.7% | 0.00% | -100.0% |
| Q1 2022 | $248,000 | -50.1% | 217,116 | -37.2% | 0.00% | 0.0% |
| Q4 2021 | $497,000 | -34.2% | 345,452 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $755,000 | -5.3% | 344,623 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $797,000 | -22.7% | 343,572 | +0.3% | 0.00% | -50.0% |
| Q1 2021 | $1,031,000 | -33.6% | 342,631 | -17.0% | 0.00% | -33.3% |
| Q4 2020 | $1,553,000 | +1.2% | 412,998 | -17.4% | 0.00% | -25.0% |
| Q3 2020 | $1,535,000 | -18.5% | 499,915 | -0.2% | 0.00% | -20.0% |
| Q2 2020 | $1,883,000 | +85.7% | 500,908 | +12.7% | 0.01% | +66.7% |
| Q1 2020 | $1,014,000 | +39.1% | 444,639 | +222.6% | 0.00% | +50.0% |
| Q4 2019 | $729,000 | +4456.2% | 137,828 | +14672.6% | 0.00% | – |
| Q4 2017 | $16,000 | +1500.0% | 933 | +805.8% | 0.00% | – |
| Q2 2015 | $1,000 | – | 103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,361,801 | $31,729,000 | 3.33% |
| NEA Management Company, LLC | 9,089,041 | $39,174,000 | 3.24% |
| Camber Capital Management LP | 3,500,000 | $15,085,000 | 0.79% |
| Redmile Group, LLC | 1,997,647 | $8,610,000 | 0.29% |
| Alambic Investment Management, L.P. | 41,698 | $180,000 | 0.14% |
| CAXTON CORP | 26,575 | $115,000 | 0.13% |
| PRENTISS SMITH & CO INC | 17,000 | $73,000 | 0.05% |
| Virtus ETF Advisers LLC | 22,580 | $97,000 | 0.02% |
| AXA S.A. | 1,825,738 | $7,868,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 30,000 | $129,000 | 0.01% |